Rainbow Children's Medicare Limited (NSE:RAINBOW)
1,350.90
+3.30 (0.24%)
At close: Dec 5, 2025
NSE:RAINBOW Revenue
Rainbow Children's Medicare had revenue of 4.45B INR in the quarter ending September 30, 2025, with 6.55% growth. This brings the company's revenue in the last twelve months to 15.66B, up 9.91% year-over-year. In the fiscal year ending March 31, 2025, Rainbow Children's Medicare had annual revenue of 15.16B with 16.88% growth.
Revenue (ttm)
15.66B
Revenue Growth
+9.91%
P/S Ratio
8.76
Revenue / Employee
3.94M
Employees
3,972
Market Cap
137.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 15.16B | 2.19B | 16.88% |
| Mar 31, 2024 | 12.97B | 1.23B | 10.51% |
| Mar 31, 2023 | 11.74B | 2.00B | 20.52% |
| Mar 31, 2022 | 9.74B | 3.24B | 49.80% |
| Mar 31, 2021 | 6.50B | -693.44M | -9.64% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Aurobindo Pharma | 325.14B |
| Cipla | 279.66B |
| Zydus Lifesciences | 244.94B |
| Apollo Hospitals Enterprise | 232.65B |
| Glenmark Pharmaceuticals | 159.97B |
| Alkem Laboratories | 138.90B |
| Mankind Pharma | 135.46B |